{"id":"https://openalex.org/W129142841","doi":"https://doi.org/10.1182/blood.v83.10.2906.2906","title":"2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia","display_name":"2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia","publication_year":1994,"publication_date":"1994-05-15","ids":{"openalex":"https://openalex.org/W129142841","doi":"https://doi.org/10.1182/blood.v83.10.2906.2906","mag":"129142841","pmid":"https://pubmed.ncbi.nlm.nih.gov/7910051"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v83.10.2906.2906","doi":"https://doi.org/10.1182/blood.v83.10.2906.2906","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v83.10.2906.2906","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113492719","display_name":"JF Seymour","orcid":"https://orcid.org/0000-0003-2188-6835","observed_orcids":["https://orcid.org/0000-0003-2188-6835"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JF Seymour","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Kurzrock","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112136910","display_name":"EJ Freireich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"EJ Freireich","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109312678","display_name":"EH Estey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"EH Estey","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":8.8264,"has_fulltext":false,"cited_by_count":205,"citation_normalized_percentile":{"value":0.98458218,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"83","issue":"10","first_page":"2906","last_page":"2911"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hairy-cell-leukemia","display_name":"hairy cell leukemia","score":0.8640000224113464},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cd4-lymphocytopenia","display_name":"CD4 lymphocytopenia","score":0.8920000195503235},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8349999785423279},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.5989999771118164},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7440000176429749},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7620000243186951},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.8569999933242798},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8051053285598755},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6567621231079102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5838731527328491},{"id":"https://openalex.org/C2780483514","wikidata":"https://www.wikidata.org/wiki/Q201299","display_name":"Hairy cell leukemia","level":3,"score":0.57610023021698},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.5258291959762573},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.496476948261261},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4480045437812805},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.44798922538757324},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3613852262496948}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007943","descriptor_name":"Leukemia, Hairy Cell","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v83.10.2906.2906","doi":"https://doi.org/10.1182/blood.v83.10.2906.2906","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v83.10.2906.2906","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:7910051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7910051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W85824607","https://openalex.org/W149140897","https://openalex.org/W159715420","https://openalex.org/W199532859","https://openalex.org/W1588652430","https://openalex.org/W1605056933","https://openalex.org/W1758976127","https://openalex.org/W1977596797","https://openalex.org/W1981730846","https://openalex.org/W1990522636","https://openalex.org/W1996352449","https://openalex.org/W2008969336","https://openalex.org/W2082762809","https://openalex.org/W2192015871","https://openalex.org/W2218543073","https://openalex.org/W2219892625","https://openalex.org/W2314659489","https://openalex.org/W2328776376","https://openalex.org/W2341518495","https://openalex.org/W2342573448","https://openalex.org/W2408302742","https://openalex.org/W2412496456"],"related_works":["https://openalex.org/W2015668632","https://openalex.org/W2009241389","https://openalex.org/W1972244910","https://openalex.org/W85824607","https://openalex.org/W2012048337","https://openalex.org/W2183753576","https://openalex.org/W149140897","https://openalex.org/W2129960987","https://openalex.org/W930885639","https://openalex.org/W2305441371"],"abstract_inverted_index":{"A":[0],"number":[1],"of":[2,28,35,46,62,79,147,170,198,218,223,239,247,258],"effective":[3],"treatments":[4],"are":[5,234],"available":[6],"for":[7,76],"patients":[8,48,55,73,88,192,240],"with":[9,25,193,241],"hairy":[10],"cell":[11],"leukemia":[12],"(HCL).":[13],"2-Chlorodeoxyadenosine":[14],"(2-CdA)":[15],"induces":[16],"more":[17,194],"than":[18,162,185,195],"80%":[19],"complete":[20],"responses,":[21],"but":[22],"is":[23,37,99],"associated":[24],"profound":[26],"suppression":[27],"CD4+":[29,109,122,151,157,215,250],"lymphocyte":[30,110,152,216],"counts.":[31],"However,":[32],"the":[33,94,220,224,237,243,248,255],"duration":[34],"each":[36],"uncertain.":[38],"We":[39],"have":[40,57,89],"analyzed":[41],"a":[42,60,77,134,168],"previously":[43],"reported":[44],"cohort":[45],"40":[47,228],"who":[49],"had":[50],"responded":[51],"to":[52,67,84,105,118,130,179,205,211,232],"2-CdA.":[53],"Eight":[54],"(20%)":[56],"relapsed":[58],"at":[59,167],"median":[61,78,108,121,169,209],"16":[63],"months":[64,81,172],"(range,":[65,82,116,128],"3":[66,92],"23":[68,171],"months).":[69,86,207],"The":[70,107,120,208],"remaining":[71],"32":[72],"were":[74,182],"observed":[75,249],"30":[80],"7":[83],"43":[85],"No":[87],"died.":[90],"At":[91],"years,":[93],"actuarial":[95],"disease-free":[96],"survival":[97],"rate":[98],"77%":[100],"(95%":[101],"confidence":[102],"interval,":[103],"70%":[104],"84%).":[106],"count":[111,217],"before":[112],"therapy":[113,174],"was":[114,126,133,145,227],"743/microL":[115],"58":[117],"2,201/microL).":[119],"nadir":[123],"after":[124,173],"treatment":[125],"139/microL":[127],"25":[129,178],"580/microL).":[131],"There":[132],"single":[135],"opportunistic":[136],"infection":[137],"and":[138,181],"no":[139],"second":[140],"malignancies":[141],"observed.":[142],"Although":[143,230],"there":[144],"evidence":[146],"some":[148],"improvement":[149],"in":[150,190,236,254],"counts":[153,158],"on":[154],"sequential":[155],"testing,":[156],"remained":[159],"significantly":[160],"lower":[161,184,221],"baseline":[163,186],"(P":[164,187],"<":[165,188],".0001)":[166],"(median,":[175,200],"237/microL;":[176],"range,":[177,203,226],"514/microL),":[180],"also":[183],".002)":[189],"those":[191],"1":[196],"year":[197],"follow-up":[199],"27":[201],"months;":[202],"13":[204],"42":[206],"time":[210],"reach":[212],"an":[213],"absolute":[214],"365/microL,":[219],"limit":[222],"normal":[225],"months.":[229],"responses":[231],"2-CdA":[233],"durable":[235],"majority":[238],"HCL,":[242],"uncertain":[244],"long-term":[245],"consequences":[246],"lymphocytopenia":[251],"suggest":[252],"caution":[253],"broad":[256],"application":[257],"this":[259],"therapy.":[260]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}